Dukhin Stanislav S, Labib Mohamed E
NovaFlux Technologies, 1 Wall Street, Princeton, NJ 08540, USA.
Colloids Surf A Physicochem Eng Asp. 2012 Sep 5;409:10-20. doi: 10.1016/j.colsurfa.2012.04.040.
Combining the approach of colloid transport with the generalized Higuchi theory of drug release and with the concept of minimum inhibitory concentration (MIC) known in microbiology, the theory of effective drug release from implants has been developed. Effective release of an antibiotic at a concentration above MIC is a necessary condition to achieve protection against infection from implants such as central catheters. The Higuchi theory in its present form is not predictive of the therapeutic effect from medical implants. The theory of effective release presented in this paper specifies two release modes, namely: one with therapeutic usefulness (effective release) and another without therapeutic effect. Therapeutic usefulness may be achieved when the antibiotic concentration, , on the implant surface kills the organisms of interest and prevents the formation and propagation of biofilm when exceeds the corresponding MIC of the released antibiotic compound. Currently, neither the Higuchi theory nor any other theory can provide such prediction. The present approach requires quantification of the antibiotic transport from the drug-polymer blend implant surface into the tissue and accounts for its coupling with drug diffusion inside the blend, a task that has not been developed in existing theories. Our solution to this task resulted in the derivation of an equation for the time of duration of effective release, , which depends on MIC, the Higuchi invariant and the characteristics of convective diffusion within the tissue. The latter characteristics include: diffusivity and diffusion layer thickness δ which is controlled by the velocity of the interstitial fluid in tissue. A smaller is favorable because transport from the catheter surface is weaker, while a thinner diffusion layer is harmful because this transport is stronger. The influence of the tangential component of interstitial velocity in the tissue is especially harmful because the diffusion within the incision exit site (IES) will be extremely enhanced such that it may decrease to zero. The incorporation of convective diffusion into the theory of antibacterial protection by means of antibiotic release has revealed that physicochemical mechanisms predict the effectiveness of antibiotic-loaded catheters and defines the conditions necessary to achieve better protection by means of combining the level of catheter loading with antibiotics and the use of wound (IES) dressing.
将胶体传输方法与广义的药物释放Higuchi理论以及微生物学中已知的最低抑菌浓度(MIC)概念相结合,已开发出植入物有效药物释放理论。以高于MIC的浓度有效释放抗生素是实现防止诸如中心静脉导管等植入物感染的必要条件。目前形式的Higuchi理论无法预测医疗植入物的治疗效果。本文提出的有效释放理论规定了两种释放模式,即:一种具有治疗作用(有效释放),另一种没有治疗效果。当植入物表面的抗生素浓度超过所释放抗生素化合物的相应MIC时,杀死目标生物体并防止生物膜形成和扩散,就可以实现治疗作用。目前,Higuchi理论和任何其他理论都无法提供这样的预测。目前的方法需要量化抗生素从药物 - 聚合物共混物植入物表面向组织中的传输,并考虑其与共混物内部药物扩散的耦合,这是现有理论尚未涉及的任务。我们对该任务的解决方案导致推导出有效释放持续时间的方程,该方程取决于MIC、Higuchi不变量以及组织内对流扩散的特性。后者的特性包括:扩散系数和由组织中间质液速度控制的扩散层厚度δ。较小的扩散系数是有利的,因为从导管表面的传输较弱,而较薄的扩散层是有害的,因为这种传输较强。组织中间质速度切向分量的影响尤其有害,因为切口出口部位(IES)内的扩散将极大增强,从而可能使有效释放持续时间降至零。通过抗生素释放将对流扩散纳入抗菌保护理论表明,物理化学机制可预测载抗生素导管的有效性,并确定通过结合导管抗生素负载水平和使用伤口(IES)敷料来实现更好保护所需的条件。